
Listerine is owned by Kenvue (NYSE: KENV), a consumer health company spun off from Johnson & Johnson in 2023. Kimberly-Clark announced a $48.7 billion acquisition of Kenvue in November 2025, expected to close in the second half of 2026. Listerine was originally invented in 1879 and previously owned by Pfizer and Warner-Lambert before J&J acquired it in 2006.
Parent Company
Acquired
2006
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Listerine | Kenvue | Wholly owned |
Dr. Joseph Lawrence invented Listerine in 1879 in St. Louis, Missouri. He developed an alcohol-based surgical antiseptic formula and named it after Sir Joseph Lister, the English surgeon who demonstrated in 1865 that carbolic acid on surgical dressings reduced post-surgical infection rates. Lawrence licensed his formula to pharmacist Jordan Wheat Lambert in 1881. Lambert founded the Lambert Pharmacal Company to commercialize the product.
Listerine was first promoted to dentists for oral care in 1895. It became the first over-the-counter mouthwash sold in the United States in 1914. For its first decades, Listerine was a modest seller. It was used as a surgical antiseptic, a floor cleaner, and even marketed as a treatment for gonorrhea. None of these applications drove significant volume.
The turning point came in the 1920s. Gerard Lambert, son of Jordan Wheat Lambert, launched an aggressive advertising campaign positioning Listerine as a cure for "chronic halitosis," a then-obscure medical term for bad breath. The campaign created consumer anxiety about a condition most people had never heard of. Revenue jumped from $115,000 in 1921 to more than $8 million by 1928. The campaign is frequently cited in marketing literature as one of the earliest examples of creating demand by medicalizing a social concern.
In 1955, Lambert Pharmacal merged with Warner-Hudnut to form Warner-Lambert Pharmaceutical Company. Warner-Lambert expanded Listerine's product line and international distribution through the 1960s and 1970s. Pfizer acquired Warner-Lambert in 2000 for approximately $90 billion, bringing Listerine into Pfizer's portfolio. In 2006, Johnson & Johnson acquired Pfizer's consumer healthcare business for approximately $16.6 billion, including Listerine.
Under J&J, Listerine expanded its product range with alcohol-free variants (Listerine Zero), whitening rinses, and specialized formulations. The brand maintained its position as the leading mouthwash in the United States and expanded internationally.
In May 2023, J&J spun off its consumer health division as Kenvue through an IPO. Listerine became part of Kenvue's Essential Health segment, which includes oral care, baby care, and wound care brands. In Q1 2026, Kenvue reported a global product restage for Listerine and began rolling out Listerine On-The-Go Alcohol Free Mouthwash Sachets in select markets.
In November 2025, Kimberly-Clark announced the $48.7 billion acquisition agreement. The deal would combine Listerine with Kimberly-Clark brands like Huggies, Kleenex, and Cottonelle.
Who owns Kenvue?
Kenvue is a publicly traded company listed on the New York Stock Exchange under the ticker KVUE. No single shareholder holds a controlling stake. Institutional investors hold the majority of shares. Johnson & Johnson fully divested its Kenvue shares in August 2023 through an exchange offer. Upon completion of the Kimberly-Clark acquisition, expected in Q4 2026, Kenvue will become a wholly owned subsidiary of Kimberly-Clark Corporation.
Is Kenvue being acquired?
Yes. On November 2, 2025, Kimberly-Clark announced a definitive merger agreement to acquire Kenvue for approximately $48.7 billion in cash and stock. Shareholders of both companies approved the transaction on January 29, 2026. The HSR waiting period expired on February 4, 2026. The transaction is expected to close in Q4 2026, subject to foreign regulatory approvals.
What is Kenvue's revenue?
Kenvue reported FY2025 net sales of $15.1 billion, down 2.1% from $15.5 billion in FY2024. FY2025 net income was $1.47 billion, with diluted EPS of $0.76 and adjusted diluted EPS of $1.08. In Q1 2026, net sales grew 3.2% and organic sales grew 1.2%. In Q2 2026, the company reported its third consecutive quarter of growth across all segments and regions.
Who is the CEO of Kenvue?
Kirk Perry serves as CEO of Kenvue. He was named interim CEO in early 2025 following the termination of previous CEO Thibaut Mongon, and was named permanent CEO in November 2025. Under Perry's leadership, Kenvue has delivered three consecutive quarters of net and organic sales growth and is executing a 2026 Restructuring Initiative targeting $250 million in pre-tax charges for supply chain optimization.
Is Kenvue still publicly traded?
Yes, Kenvue continues to trade on the New York Stock Exchange under the ticker KVUE as of August 2026. Upon completion of the Kimberly-Clark acquisition, expected in Q4 2026, Kenvue shares will be delisted as the company becomes a wholly owned subsidiary of Kimberly-Clark.
When was Kenvue founded?
Kenvue was spun off from Johnson & Johnson in May 2023 via an IPO that raised $3.8 billion. J&J completed the full separation in August 2023 through an exchange offer. The company was created to operate independently as a focused consumer health company, allowing J&J to concentrate on its pharmaceutical and medical device businesses.
What brands does Kenvue own?
Kenvue owns Tylenol, Listerine, Band-Aid, Neutrogena, Aveeno, Zyrtec, Johnson's, Motrin, Benadryl, Sudafed, Pepcid, Imodium, Nicorette, Visine, and Calpol. These brands hold number-one or number-two market positions in their respective categories.
Where is Kenvue headquartered?
Kenvue is headquartered in Summit, New Jersey, USA. The company relocated from Skillman, New Jersey, where it was initially based following the spin-off from Johnson & Johnson. Kenvue is incorporated in Delaware and maintains manufacturing facilities, research and development centers, and distribution networks across the United States, Europe, Asia, and Latin America.
What is the Kimberly-Clark Kenvue merger?
The Kimberly-Clark Kenvue merger is a pending acquisition announced on November 2, 2025, under which Kimberly-Clark will acquire all outstanding Kenvue shares in a cash and stock transaction valued at approximately $48.7 billion enterprise value. The combined company would generate approximately $32 billion in annual revenue and $7 billion in adjusted EBITDA. Kimberly-Clark identified $1.9 billion in cost synergies and $500 million in revenue synergies. The transaction is expected to close in Q4 2026.
Kenvue's sustainability framework covers responsible ingredient sourcing, sustainable packaging, and environmental impact reduction. Listerine operates within this framework rather than maintaining a brand-specific sustainability program.
Kenvue has committed to making all packaging recyclable, reusable, or compostable where infrastructure allows. Listerine bottles are made of HDPE plastic, which is widely recyclable. The brand has incorporated recycled materials into some packaging components. Kenvue's broader sustainability goals include reducing virgin plastic use and improving recyclability across its portfolio.
Listerine is not certified cruelty-free by Leaping Bunny or PETA. Kenvue's animal testing policies are governed by regulatory requirements, as some markets require animal testing for certain product categories. The brand does not hold vegan certification. The sustainabilityFlags frontmatter field is empty because no independently verified certifications apply to Listerine specifically.
Kenvue has implemented water reduction initiatives at its manufacturing facilities. The company reports on water efficiency in production processes and has set targets for reducing water usage per unit of output.
Listerine is consistently ranked as the number one dentist-recommended mouthwash brand in the United States. This ranking is based on surveys conducted by independent market research firms among dental professionals.
The brand holds the American Dental Association (ADA) Seal of Acceptance for multiple products. The ADA Seal is awarded after scientific review of clinical evidence demonstrating safety and efficacy. Listerine's clinical research program has published studies in peer-reviewed dental journals including the Journal of the American Dental Association (JADA).
Listerine has been recognized by market research firms as the leading mouthwash brand globally. The brand's market share leadership and brand equity have earned it positions in Kantar BrandRankings and similar consumer brand studies.
FTC Advertising Claims Ruling (1976): The Federal Trade Commission ruled that Listerine's claims about preventing or alleviating colds and sore throats were misleading. The FTC stated Listerine had "no efficacy" against colds or sore throats. Warner-Lambert was ordered to stop making these claims and was required to include disclaimers in advertising stating "Listerine will not help prevent colds or sore throats or lessen their severity." The ruling cost Warner-Lambert $10 million in corrective advertising and fundamentally shifted Listerine's marketing toward oral care benefits.
Agent Cool Blue Recall (2007): In April 2007, McNeil-PPC, then a Johnson & Johnson subsidiary, disclosed potential contaminants in all Listerine Agent Cool Blue products sold since their 2006 launch. The company issued a voluntary recall of all bottles. No serious injuries were reported. The recall was a precautionary measure to ensure consumer safety.
Alcohol Content Scrutiny: Listerine has faced ongoing scrutiny over the alcohol content in its traditional formulations. Original Listerine contains approximately 26.9% alcohol. Concerns have been raised about mouthwash alcohol and its potential connection to oral cancer, though clinical evidence remains inconclusive. Consumer demand for alcohol-free options led to the development of Listerine Zero, which uses different active ingredients to maintain efficacy without alcohol.
Packaging Environmental Concerns: Listerine has faced criticism over the environmental impact of its plastic packaging. The brand has responded by incorporating recycled materials and participating in recycling programs, though the large volume of plastic bottles sold annually remains a sustainability challenge.
No direct competitors found in the same category. This could be because Listerineoperates in a unique market segment or we're still building our competitor database.
Looking for brands with different ownership structures? These similar brands are not owned by Kenvue, giving you alternative choices that support different corporate structures.
Beauty Personal CareOwned by Evyap
Turkish brand of men's grooming and shaving products manufactured and marketed by Evyap, known for affordable quality shaving soaps.
Arko is privately owned, unlike Listerine which is under a publicly traded parent company.
Beauty Personal CareOwned by Nexus Capital Management
American direct-to-consumer razor and grooming brand known for its subscription model and viral marketing.
Dollar Shave Club is privately owned, unlike Listerine which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Turkish beauty and bath soap brand manufactured by Evyap. Sold in over 100 countries. Known for natural ingredients including olive oil, shea butter, and coconut. Market leader in Eastern Europe and Central Asia.
Duru is privately owned, unlike Listerine which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Mass-market soap and personal care brand owned by Evyap, sold in over 100 countries with strong positions in Eastern Europe and the Middle East.
Fax is privately owned, unlike Listerine which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Men's personal care and grooming brand owned by Evyap, a privately held Turkish personal care company founded in 1927. Gibbs offers shaving products, deodorants, and grooming items primarily in European, Middle Eastern, and Central Asian markets.
Gibbs is privately owned, unlike Listerine which is under a publicly traded parent company.
Beauty Personal CareOwned by Great Clips, Inc.
Value hair salon franchise brand owned by Great Clips, Inc. and operated through more than 4,400 franchisee-owned salons.
Great Clips is privately owned, unlike Listerine which is under a publicly traded parent company.
Discover popular brands and companies in the Beauty & Personal Care category and related searches from other users.

Italian luxury fragrance and grooming brand founded in Parma in 1916, owned by LVMH since 2001. Known for its signature Colonia fragrance and a full range of home and lifestyle products made in Italy.

Turkish antibacterial soap and personal hygiene brand owned by Evyap, one of Turkey's largest consumer goods manufacturers. Activex uses silver ion technology and is sold primarily in Turkey and Middle Eastern markets.

Procter & Gamble's feminine hygiene brand launched in 1983, holding approximately 27% global market share in menstrual pads and sold in more than 100 countries.